Evidence map›Paper›PMID 19205619›Full record

ArticleClinical and experimental medicine2009

Significance of survivin, caspase-3, and VEGF expression in thyroid carcinoma.

Hai-Yan Zhang, Xin Meng, Zhen-Xian Du, Chang-Qing Fang, Guo-Liang Liu, Hua-Qin Wang, Wei-Wei Deng

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical and experimental medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Hai-Yan ZhangDepartment of Geriatrics, The First Affiliated Hospital, China Medical University, Heping District, 110001 Shenyang, Liaoning Province, People's Republic of China. zhy_doctor@hotmail.com
Xin Meng
Zhen-Xian Du
Chang-Qing Fang
Guo-Liang Liu
Hua-Qin Wang
Wei-Wei Deng
China Medical University · CNFirst Hospital of China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To investigate the clinical significance of survivin, caspase-3, and vascular endothelial growth factor expression in a subset of thyroid carcinoma and their correlation with prognosis. Sixty-eight cases of thyroid carcinoma (TC), 12 cases of thyroid adenoma (TA) and 10 cases of normal thyroid tissue (NT) were involved in immunohistochemical and real-time RT-PCR analyses for survivin, caspase-3, and VEGF expression. Statistical analyses were performed for differential expression among NT, TA and TC, correlations of their expression with the clinicopathological parameters of TC including histological typing, clinical staging and lymphnode metastasis, and relationship of survivin with caspase-3 or VEGF in TC. We observed higher mRNA expression and positive immunostaining for survivin and VEGF in TC compared with TA and NT, with a significant positive correlation among them and significant correlations with histological typing, clinical staging and lymphnode metastasis in TC, but we could not find any significance of caspase-3 in TC and its significant relationship with survivin expression. Our results indicate that survivin and VEGF are unfavorable molecules for TC evolution and prognosis, and possess positive correlation in TC.

Indexed as

AdultAgedBiomarkers, TumorCaspase 3FemaleHumansImmunohistochemistryInhibitor of Apoptosis ProteinsMaleMicrotubule-Associated ProteinsMiddle AgedPrognosisReverse Transcriptase Polymerase Chain ReactionSeverity of Illness IndexSurvivinThyroid NeoplasmsBiomarkers, TumorBIRC5 protein, humanCaspase 3Inhibitor of Apoptosis ProteinsMicrotubule-Associated ProteinsSurvivinVascular Endothelial Growth Factor A

Identifiers

PMID19205619
OpenAlexW1993976555

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.